Tocut Milena, Vaknine Hanan, Potachenko Paulina, Elias Sorin, Zandman-Goddard Gisele
Department of Internal Medicine C, Wolfson Medical Center, Holon, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Isr Med Assoc J. 2020 Oct;22(10):645-647.
Histiocytic sarcoma (HS) is a rare hematopoietic malignancy originating from the monocyte/macrophage bone marrow lineage. HS can occur in isolation or in association with other hematological neoplasms such as non-Hodgkin lymphoma (NHL), myelodysplasia, or acute leukemia. Clinically, HS can affect lymph nodes, gastrointestinal tract, skin, bone marrow, and spleen as well as the central nervous system. Most cases of HS follow an aggressive clinical course, with most patients dying of progressive disease within one year of diagnosis.
组织细胞肉瘤(HS)是一种罕见的造血系统恶性肿瘤,起源于单核细胞/巨噬细胞骨髓谱系。HS可单独发生,或与其他血液系统肿瘤如非霍奇金淋巴瘤(NHL)、骨髓发育异常或急性白血病相关。临床上,HS可累及淋巴结、胃肠道、皮肤、骨髓、脾脏以及中枢神经系统。大多数HS病例临床病程呈侵袭性,大多数患者在诊断后一年内死于疾病进展。